PRL-1 Antibodies

Santa Cruz Biotechnology provides a broad selection of PRL-1 monoclonal antibodies for research focused on understanding PRL-1 protein functions. The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PRL-1, or phosphatase of regenerating liver-1, belongs to the protein tyrosine phosphatase family and plays a critical role in cell signaling, proliferation, and migration. Research has shown that PRL-1 significantly influences cancer progression and metastasis, making it a valuable target for therapeutic research. Understanding PRL-1 functions can provide insights into various cellular processes and disease mechanisms. PRL-1 monoclonal antibodies enable researchers to explore cellular pathways and molecular interactions in both normal and pathological conditions. Investigating PRL-1 expression patterns and regulatory mechanisms can lead to breakthroughs in cancer research and potential therapeutic strategies. Current studies indicate that PRL-1 may serve as a biomarker for several types of cancer, highlighting its importance in diagnostic applications. Santa Cruz Biotechnology monoclonal antibodies support the scientific community's efforts to advance understanding of PRL-1's role in health and disease.